stockportfolio.pro
Vertex Pharmaceuticals Incorporated Gross Profit 2008–2025
Vertex Pharmaceuticals Incorporated (VRTX) annual gross profit by fiscal year, computed from SEC filings. Compound growth +12.7%/yr over 17 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $10.35B | 86.2% | +9.1% |
| FY 2024 | $9.49B | 86.1% | +10.3% |
| FY 2023 | $8.61B | 87.2% | +9.6% |
| FY 2022 | $7.85B | 87.9% | +17.7% |
| FY 2021 | $6.67B | 88.1% | +22.0% |
| FY 2020 | $5.47B | 88.1% | +51.3% |
| FY 2019 | $3.62B | 86.8% | +37.0% |
| FY 2018 | $2.64B | 86.6% | +19.2% |
| FY 2017 | $2.21B | 88.9% | +48.4% |
| FY 2016 | $1.49B | 87.6% | +63.0% |
| FY 2015 | $915.18M | 88.7% | +69.3% |
| FY 2014 | $540.69M | 93.2% | -51.9% |
| FY 2013 | $1.12B | 92.7% | -13.0% |
| FY 2012 | $1.29B | 84.5% | -4.2% |
| FY 2011 | $1.35B | 95.5% | — |
| FY 2010 | — | — | — |
| FY 2009 | — | — | — |
| FY 2008 | — | — | — |
Source: Vertex Pharmaceuticals Incorporated SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Vertex Pharmaceuticals Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeVertex Pharmaceuticals Incorporated — frequently asked questions
What is Vertex Pharmaceuticals Incorporated's gross profit?
Vertex Pharmaceuticals Incorporated (VRTX) reported gross profit of $10.35B for fiscal year 2025, per its SEC filings.
How has Vertex Pharmaceuticals Incorporated's gross profit changed over time?
Between fiscal 2008 and 2025, VRTX's gross profit grew at roughly 12.7% per year (compound annual rate), from $1.35B to $10.35B.
Where does this data come from?
Figures are computed from Vertex Pharmaceuticals Incorporated's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.